Breast Cancer Just Got 3 New Drugs — Here's What Changed If you have estrogen receptor positive, HER2 negative breast cancer, the standard of care was just rewritten. The drug oncologists have reached for in hormone receptor
By Jay Chaplin - July 17, 2026